The WHO on Tuesday maintained that roughly two billion people could become infected with the H1N1 (swine flu) virus, Reuters reports.
Pneumonia & Flu
Also In Global Health News: Plague In China; U.S. Contribution To Clean Water Initiatives; TB Vaccine Trial; HIV In Mozambique; New HIV Strain
Third Person In China Dies Of Pneumonic Plague, Officials Seal-Off Area A third person died of pneumonic plague in China on Monday, local health authorities said, Xinhua reports. The outbreak began on July 30 and an additional nine people in the town of ZiketanÂ are reportedly ill (8/3). “Pneumonic plague, which…
The Agence-France Press examines the debate over how much developed countries are spending to fight the H1N1 virus.
“A U.S. plan to rely on swine flu vaccines without ingredients to stretch the supply [known as adjuvants] would reduce the number of available shots just when other countries need them most, the British journal Lancet said in an editorial,” Bloomberg writes.
During a meeting in Atlanta on Wednesday, a “federal advisory committee issued sweeping guidelines â€¦ for a vaccination campaign against the pandemic swine flu strain, identifying more than half the U.S. population as targets for the first round of vaccinations,” CNN reports (Hellerman, 7/29).
Health officials are growing increasingly concerned over the impact the H1N1 (swine) flu is having on populations living in Latin America, a region “which accounts for around two-thirds of the 816 confirmed deaths so far from the disease,” the AFP/channelnewsasia.com reports.
The WHO on Friday said the “H1N1 swine-flu virus could infect up to two billion people over the next two years – about one of every three people in the world,” VOA News reports.
The Asian Strategic Alliance for Pneumococcal Disease Prevention (ASAP) is calling for the pneumonia vaccine to become an official part of India’s required list of immunizations, the Times of India reports.
“Global health officials are scrambling to try to prevent the spread of the H1N1 swine flu virus, with U.S. officials moving Thursday with a recommendation that the Food and Drug Administration approve or license a [new H1N1] vaccine,” without waiting on the results from “clinical trials to test its safety and efficacy,” Wall Street Journal reports (Dooren/Winning, 7/24).
The race to develop a H1N1 (swine flu) vaccine before the fall flu season ramped up Wednesday, after Australia launched the first human trials of the H1N1 vaccine and scientists from the U.S., China and Britain announced plans for human trials of an H1N1 vaccine in the coming weeks, AFP/France24.com reports.